During B lymphopoiesis, recombination of the locus encoding the immunoglobulin k-chain complex (Igk) requires expression of the precursor to the B cell antigen receptor (pre-BCR) and escape from signaling via the interleukin 7 receptor (IL-7R). By activating the transcription factor STAT5, IL-7R signaling maintains proliferation and represses Igk germline transcription by unknown mechanisms. We demonstrate that a STAT5 tetramer bound the Igk intronic enhancer (E ki ), which led to recruitment of the histone methyltransferase Ezh2. Ezh2 marked trimethylation of histone H3 at Lys27 (H3K27me3) throughout the k-chain joining region (J k ) to the k-chain constant region (C k ). In the absence of Ezh2, IL-7 failed to repress Igk germline transcription. H3K27me3 modifications were lost after termination of IL-7R-STAT5 signaling, and the transcription factor E2A bound E ki , which resulted in acquisition of H3K4me1 and acetylated histone H4 (H4Ac). Genome-wide analyses showed a STAT5 tetrameric binding motif associated with transcriptional repression. Our data demonstrate how IL-7R signaling represses Igk germline transcription and provide a general model for STAT5-mediated epigenetic transcriptional repression.
B lymphopoiesis is driven by the sequential rearrangement and expression of immunoglobulin heavy chains (µ-chains) and then immunoglobulin light chains (κ-chain followed by λ-chain). Each recombination constitutes a discrete transition in which rearrangements able to support the expression of a surface receptor are selected for further development 1 . The immunoglobulin µ-chain assembles with surrogate light chain and immunoglobulin α-chain and β-chain to form a precursor to the B cell antigen receptor (pre-BCR) that first expands populations of pre-B cells bearing a single in-frame heavychain rearrangement and then initiates recombination of the locus encoding the immunoglobulin κ-chain complex (Igk) [2] [3] [4] . Initial clonal proliferation occurs in the context of bone marrow-derived signals such as interleukin 7 (IL-7) 5,6 . However, this cooperation is transient, and B cell progenitors must exit the cell cycle before initiating Igk recombination 7 .
Igk recombination requires that the locus be accessible to the recombination-activating proteins RAG-1 and RAG-2 (refs. 8, 9) , and Igk germline transcription correlates with accessibility and precedes recombination 10, 11 . Deletion of either the intronic Igk enhancer (E κi ; Mouse Genome Informatics accession code, 1354193) in the κ-chain joining region-constant region (J κ -C κ ) intron or, to a lesser degree, the 3′ C κ enhancer diminishes Igk germline transcription and recombination [12] [13] [14] , whereas deletion of both enhancers completely blocks Igk rearrangement 13 . In vivo experiments have demonstrated that binding of the transcription factor E2A to two sites in E κi (E-boxes κE1 and κE2) are required for Igk transcription and rearrangement [15] [16] [17] [18] . In contrast, the transcription factors IRF4 and IRF8 bind the 3′ C κ enhancer and are necessary for Igk recombination in vivo and for progression beyond the large pre-B cell stage [19] [20] [21] .
Germline transcription of Igk and the initiation of Igk recombination are also associated with the acquisition of activating post-translational modifications of histones 19, 22, 23 . Binding of E2A correlates with acquisition of the activating marks of acetylation of histone H3 (H3Ac) and trimethylation of histone H3 at Lys4 (H3K4me3) at the J λ segments 24 and, genome-wide, binding of E2A at enhancers is associated with more monomethylation of H3K4 (H3K4me1) 25 . Furthermore, the E-boxes contained in E κi are necessary for J κ to acquire open chromatin marks in pre-B cells 23 . Post-translational modifications of histone are particularly important for immunoglobulin gene recombination, as RAG-2 is recruited to and activated by H3K4me3 (refs. 26,27) ; this provides a direct link between posttranslational modifications and recombination.
Activation of the kinase Erk mediated by the pre-BCR results in more nuclear E2A available for binding to E κi (ref. 16 ). Pre-BCR signaling is also associated with the acquisition by the Igk locus of the epigenetic marks of open chromatin 23 . Such data are consistent with observations showing that expression of the pre-BCR directs both exit from the cell cycle and the induction of Igk recombination 16, [28] [29] [30] at the pre-B cell stage.
The pre-BCR-mediated differentiation program is antagonized by signaling via the IL-7 receptor (IL-7R), which promotes proliferation and represses Igk recombination. Downstream of IL-7R, activated transcription factor STAT5 enhances transcription of the cell-cycle effector cyclin D3 while repressing Igk germline transcription 16, 31 . Pre-B cells must escape the effects of IL-7R signaling to effectively initiate Igk recombination. Escape can be regulated by intrinsic mechanisms 32 and extrinsic mechanisms, including movement of pre-B cells along chemokine gradients into IL-7-deficient niches in the bone marrow 33 .
An important facet of this interaction between IL-7R and the pre-BCR is STAT5-mediated repression of Igk recombination 16, 31 . STAT5 binds directly to E κi and can prevent the recruitment of E2A 16, 19 . However, it is not clear if this apparent competition is sufficient to explain STAT5-mediated repression. Here we demonstrate that STAT5 bound as a tetramer to E κi and enabled recruitment of the histone methyltransferase Ezh2 that decorated E κi , the J κ cluster and C κ with the repressive mark of trimethylation of histone H3 at Lys27 (H3K27me3) 22 . Genome-wide analysis indicated that the Igk locus provides an example of a general mechanism by which STAT proteins can directly repress locus accessibility and transcription.
RESULTS
Functional importance of the binding of STAT5 at kS2 IL-7R-mediated activation of STAT5 represses Igk transcription in pro-B cells by binding directly to E κi , and this is associated with inhibition of E2A recruitment 16, 31 . Examination of E κi with the transcription factor-binding site search program TFSEARCH identified two potential STAT-binding sites (κS1 and κS2) that closely matched the STAT consensus binding sequence 5′-TTCN 3 GAA-3′ (GAS (interferon-γ-activated site), where 'N 3 ' is any three amino acids; Fig. 1a ). The site κS1 (5′-TTCTTGGTA-3′) was 60 base pairs (bp) upstream of the binding site for the transcription factor NF-κB 17, 34 . The κS2 site (5′-TTCCGAGAG-3′) overlapped the NF-κB-binding site and was only 2 bp upstream of the core κE1 site 31 (Fig. 1a) .
To determine if either of those sites (κS1 or κS2) could bind STAT5, we cultured nuclear extracts of pre-B cells deficient in both IRF4 and IRF8 (Irf4 -/-Irf8 -/-) with IL-7 and biotinylated oligonucleotide probes corresponding to κS1 and κS2 and analyzed them by electrophoretic mobility-shift assay (EMSA; Fig. 1b ). We detected one complex bound to the wild-type κS1 probe, whereas two major complexes with low electrophoretic mobility and one minor complex with high electrophoretic mobility bound to the wild-type κS2 probe. These complexes were attenuated by the addition of antibody to STAT5 (anti-STAT5) or excess unlabeled wild-type oligonucleotides or by mutation of the corresponding putative STAT5-binding site. These data indicated that one STAT5-containing complex detectably bound κS1, whereas three distinct STAT5-containing complexes bound κS2.
To assess the effect of IL-7R signaling on the binding of STAT5 to E κi , we cultured nuclear extracts of Irf4 -/-Irf8 -/pre-B cells with IL-7 at a high concentration (10 ng/ml) or low concentration (0.1 ng/ml) and biotinylated oligonucleotide probes corresponding to the κS2 site ( Fig. 1c) or probes corresponding to binding sites for the transcription factors Oct or Pax5 ( Fig. 1d ) and then analyzed them by EMSA. As expected, in the presence of IL-7, STAT5-containing complexes bound the wild-type κS2 probe but not the mutant κS2 probe. These complexes were attenuated by the addition of anti-STAT5 or excess unlabeled wild-type oligonucleotides. In contrast, the complex was not diminished by the addition of unlabeled oligonucleotide containing mutations in the κS2 binding motif or by the addition of isotypematched control antibodies ( Fig. 1c) (e) Dual-luciferase assay of lysates of COS-7 cells transfected for 48 h with luciferase reporter plasmid containing Eκi(WT), Eκi(mκS1), Eκi(mκS2) or Eκi(mκS1-mκS2) (key) plus pRL-TK and control plasmid or combinations of plasmids encoding E47, E12 and/or CA-STAT5B (horizontal axis). AU, arbitrary units. *P < 0.001, versus the Eκi(WT) control; **P < 0.01, versus the Eκi(mκS1) control; ***P < 0.001 and † P < 0.01, versus the Eκi(mκS2) control; ‡ P < 0.001, versus the Eκi(mκS1-mκS2) control (unpaired t-test). Data are representative of three independent experiments (average ± s.d. in e). A r t i c l e s a probe corresponding to the κS1 site (data not shown). IL-7 did not affect the binding of complexes to the Oct or Pax5 probe ( Fig. 1d) .
We next examined the ability of STAT5 to repress E κi enhancer activity. We cloned wild-type E κi into a pGL3 luciferase reporter vector containing a SV40 promoter-luciferase gene cassette. We transfected that wild-type reporter (Eκi(WT)) or similar reporters with mutation of either κS1 (Eκi(mκS1)) or κS2 (Eκi(mκS2)) or both κS1 and κS2 (Eκi(mκS1-mκS2)) into COS-7 monkey kidney cells together with the renilla luciferase plasmid pRL-TK (internal control) and combinations of plasmids encoding the transcription factors E47, E12 and/or constitutively active STAT5B (CA-STAT5B) or control plasmid 16 . At 48 h after transfection, we measured luciferase activity by a dual-luciferase reporter assay. Expression of E47 or E12 enhanced E κi activity, whereas coexpression of CA-STAT5B repressed E2A-mediated induction of E κi (Fig. 1e) . Mutation of κS1 alone did not inhibit the ability of STAT5 to repress E κi ; however, mutation of κS2 or both κS1 and κS2 progressively inhibited the ability of STAT5 to repress E2A-mediated activation of E κi (Fig. 1e) . These data indicated that κS2 was more important than κS1 in STAT5-mediated repression of E κi .
Competition between STAT5 and E2A
We speculated that STAT5 might repress E κi by competing with E2A for binding. If so, increasing the distance between the κS2 and κE1 binding sites should mitigate STAT5-mediated E κi repression. Therefore, we created mutated versions of Eκi(WT) in which we introduced spacers of three, six or nine adenine residues between the κS2 and κE1 sites (Eκi(κS2-3A-κE1), Eκi(κS2-6A-κE1) and Eκi(κS2-9A-κE1), respectively; Fig. 2a ). We then transfected wildtype or mutant luciferase reporters into COS-7 cells along with pRL-TK, plasmids encoding E47 or CA-STAT5B, or a control plasmid, singly or in combination. We found that increasingly longer adenine spacers progressively attenuated STAT5-mediated repression, such that with the nine-adenine spacer, we observed no significant repression ( Fig. 2b) . We obtained similar results with a plasmid encoding E12 (Supplementary Fig. 1a ). Overall, these data were consistent with physical competition between STAT5 and E2A.
We next directly investigated if STAT5 competed with E2A at E κi . We isolated DNA from COS-7 cells transfected as described above and expressing either the Eκi(WT) or Eκi(κS2-9A-κE1) reporter. We immunoprecipitated protein-bound DNA from samples with anti-STAT5 or anti-E47 and amplified DNA in the immunoprecipitates by quantitative PCR with primers specific for the E κi reporter. In cells expressing Eκi(WT), both E47 and CA-STAT5B bound the enhancer when expressed individually ( Fig. 2c) . However, when both E47 and CA-STAT5B were expressed together, only the binding of CA-STAT5B was preserved. Consistent with the direct competition at wild-type E κi , both CA-STAT5B and E47 bound to Eκi(κS2-9A-κE1) when expressed together ( Fig. 2d) .
E2A activates Igk transcription through both the κE1 and κE2 sites 17 . Therefore, to determine if STAT5 repressed E2A-mediated activation of E κi through either κE1 or κE2, we transiently transfected COS-7 cells with Eκi(WT), Eκi(mκE1) or Eκi(mκE2) in the presence of ectopically expressed E47 or CA-STAT5B or both E47 and CA-STAT5B ( Supplementary Fig. 1b) . Notably, STAT5 repressed both κE1and κE2-directed E2A-mediated activation. STAT5 is unlikely to repress κE2-mediated activation by direct competition, as κE2 is not in proximity to either κS1 or κS2. Therefore, we next investigated if STAT5 could epigenetically regulate E κi .
Epigenetic repression of E ki by STAT5
The initiation of Igk transcription in vivo is associated with activating histone marks at J κ genes 23 . However, epigenetic regulation of E κi has not been fully characterized 19 . Therefore, we first examined the epigenetic regulation of E κi during B lymphopoiesis. We isolated pro-B cells (B220 + CD43 hi IgM -Lin -), large pre-B cells (B220 + CD43 lo-neg IgM -Lin -FSC hi ), small pre-B cells (B220 + CD43 lo-neg IgM -Lin -FSC lo ) and immature B cells (B220 + CD43 -IgM + IgD -Lin -) by flow cytometry from wild-type bone marrow and analyzed them by quantitative chromatin immunoprecipitation (ChIP) 16 with antibody to acetylated histone H4 (H4Ac), antibody to the enhancer-specific mark H3K4me1 (ref. 35 ) and anti-H3K27me3, followed by PCR primers specific for E κi . As expected, in pro-B cells and large pre-B cells in which Igk transcription is quiescent, repressive H3K27me3 marks predominated ( Fig. 3a) . After transition to the small pre-B cell stage and the initiation of Igk transcription 36 , marks of active enhancers (H4Ac and H3K4me1) predominated.
We next sought to determine whether IL-7R signaling regulated the accessibility of E κi . In cultures with IL-7, Irf4 -/-Irf8 -/-B cell progenitors resemble proliferating pre-B cells. However, after withdrawal of IL-7, they exit the cell cycle and initiate Igk recombination 19 . Therefore, we cultured Irf4 -/-Irf8 -/pre-B cells with IL-7 at a high concentration (10 ng/ml) or low concentration (0.1 ng/ml) and analyzed them by ChIP as described above. As in primary pro-B cells
Binding (% of input) --- and large pre-B cells, H3K27me3 predominated at E κi in Irf4 -/-Irf8 -/pre-B cells cultured with a high concentration of IL-7 ( Fig. 3b) . After withdrawal of IL-7, H3K27me3 was attenuated and histones associated with E κi became decorated, with acetylation of H4 and and monomethylation of H3K4. These data suggested that IL-7R epigenetically regulates E κi .
As IL-7 modulates the epigenetic histone marks associated with E κi , we next determined if this function of IL-7 could be supplanted by activated STAT5. We infected cultured Irf4 -/-Irf8 -/pre-B cells with control retrovirus encoding green fluorescent protein (GFP) or retrovirus encoding CA-STAT5B, then isolated GFP + cells by flow cytometry and recultured them with a low concentration of IL-7. We then analyzed cell aliquots by ChIP as described above. As expected, in mock-infected cells, E κi was marked with H4Ac and HeK4me1 (Fig. 4a) . However, in cells expressing STAT5B, E κi was decorated mainly with H3K27me3. These results indicated that downstream of IL-7R signaling, STAT5 maintained H3K27me3 at E κi and prevented the acquisition of markers of open chromatin associated with entry into the small pre-B cell pool.
Epigenetic activation of E ki by E2A
Downstream of the pre-BCR, Erk activation coordinately induces E2A and represses the E2A inhibitor Id3 (ref. 16 ). The resulting free nuclear E2A, in greater abundance, can then bind Igk enhancers and activate Igk transcription 15, 17, 37, 38 . Therefore, we next examined whether the acquisition of active histone modifications at E κi after IL-7 withdrawal was dependent on E2A. We used Irf4 -/-Irf8 -/pre-B cells expressing a retrovirus-encoded fusion protein of the estrogen receptor and inducible Id3 and cultured these cells with IL-7 at a high concentration (10 ng/ml) or low concentration (0.1 ng/ml) in the presence or absence of 4-OH-tamoxifen. We then did ChIP with anti-H4Ac, anti-H3K4me1 and anti-H3K27me3 followed by PCR with primers specific for E κi . In the presence of IL-7, in Irf4 -/-Irf8 -/pre-B cells treated with either tamoxifen (induced) or vehicle only (uninduced), the histones in the E κi region were marked mainly with H3K27me3 ( Fig. 4b) . However, after IL-7 withdrawal in tamoxifen-treated cells, E κi lacked both activating and repressive histone modifications. These data indicated that the balance between STAT5 and E2A determines the epigenetic status of E κi .
STAT5 binding confers H3K27me3 repressive marks E κi is positioned approximately 1.5 kilobase (kb) downstream of the 3′ J κ gene cluster and 1 kb upstream of C κ (Fig. 4c) . This close positioning raised the possibility that recruitment of STAT5 to E κi could regulate the accessibility of these flanking regions. To assess this, we cultured Irf4 -/-Irf8 -/pre-B cells with control expression retrovirus or retrovirus encoding CA-STAT5B, in a low concentration of IL-7, and assessed H3K27me3 at the J κ , C κ and E κi regions by ChIP (Fig. 4c) . In cells expressing CA-STAT5B, we observed significant trimethylation of H3K27 throughout the J κ and C κ regions. In contrast, expression of CA-STAT5B did not enhance H3K27me3 in the κ-chain variable region (V κ ) or 3′ E κ . These data suggested that direct binding of STAT5 to E κi epigenetically repressed Igk transcription.
Binding of tetrameric STAT5 to E ki in kS2 recruits Ezh2
Our results reported above demonstrated that although STAT5 had no intrinsic histone-methyltransferase activity, STAT5 targeted H3K27me3 to the Igk locus. In lymphocytes, two members of the polycomb group family, Ezh1 and Ezh2, are known to transmethylate H3K27me2 to generate H3K27me3 (ref. 39 ). Of those two, only Ezh2 is abundantly expressed during B lymphopoiesis, for which it has an obligatory role 40 . To assess the ability of STAT5 to recruit Ezh2, we cultured Irf4 -/-Irf8 -/pre-B cells with IL-7 at a high or low Mock + IgG CA-STAT5B + H3K27me3 Mock + H3K27me3 A r t i c l e s concentration. We then analyzed nuclear extracts by ChIP with anti-STAT5, resolved the immunoprecipitates by SDS-PAGE, transferred them to membranes and probed with anti-STAT5 or anti-Ezh2. At the high concentration of IL-7, but not at the low concentration of IL-7, we readily detected both STAT5 and Ezh2 after ChIP with anti-STAT5 ( Fig. 5a) , even though both molecules were readily detected in samples at a low concentration of IL-7. We obtained similar results with cultured RAG-2-defcient (Rag2 -/-) pro-B cells (data not shown).
In contrast, after immunoprecipitation of STAT5 from nuclear lysates in the absence of chromatin crosslinking, there was no detectable association with Ezh2 (Fig. 5b) . These data suggested that when bound to chromatin DNA, STAT5 recruits Ezh2. The observations noted above raised the following central question: how could STAT5 recruit Ezh2 to E κi and act as a repressor, when it usually functions as a potent transcriptional activator? Conventionally, STAT proteins are recruited as dimers to GAS motifs of the sequence TTCN 3 GAA 41 . However, STAT5 proteins can also bind as a dimer of dimers (a tetramer) formed through homotypic interactions of N-terminal domains 42 . In vivo, STAT5 tetramers have been associated with aberrant transcriptional patterns and leukemogenesis 43 . In vitro, STAT5 tetramers are recruited to DNA sequences containing tandem GAS motifs in which partial GAS elements are separated by 4-19 nucleotides 44 . Examination of the κS2 site showed 3′ sequences containing partial GAS motifs (TCT, TTG and TAA) 4-12 nucleotides downstream (Fig. 1a) . Therefore, we determined if STAT5 bound κS2 as a tetrameric complex.
By EMSA of nuclear preparations of pre-B cells, we found that three STAT5-containing complexes with different electrophoretic mobilities bound κS2 (Fig. 1b,c) . To compare those with complexes formed by STAT5 dimers or tetramers, we incubated nuclear preparations of CA-STAT5-overexpressing 3T3 mouse fibroblasts with nucleotide probes known to bind only STAT5 dimers or STAT5 tetramers or both dimers and tetramers 44 (Supplementary Table 1) . The results showed that the κS2-bound complex with fastest migration obtained from Irf4 -/-Irf8 -/nuclear preparations corresponded to the STAT5 dimer, whereas the intermediate complex corresponded to the STAT5 tetramer (Fig. 5c) ; κS2 also formed a third distinct complex with slow migration.
We next examined the relationships among the various κS2 binding complexes and Ezh2 recruitment. Preincubation with anti-STAT5 abolished all three κS2 binding complexes, whereas anti-Ezh2 diminished only the two complexes that migrated more slowly (Figs. 5d,e ). Binding of tetrameric STAT5 is predicted to be dependent on the 3′ partial GAS motifs, but binding of dimeric STAT5 is not. Indeed, mutation of these motifs (κS2-end-Mut; Supplementary Table 1 ) disrupted the two complexes that migrated more slowly by electrophoresis, but not the putative dimer complex. Finally, we directly examined the ability of the wild-type κS2(WT) probe and κS2-end-Mut probe to precipitate STAT5 and Ezh2 from Irf4 -/-Irf8 -/nuclear preparations. Although both sequences bound STAT5, only κS2(WT) also detectably precipitated Ezh2 (Fig. 5f) . These data suggested that STAT5 tetramers, bound to the tetrameric motif, recruited Ezh2. Ezh2 is usually recruited to DNA in a multimeric PRC2 complex (polycomb repressive complex 2) that contains, among other components, EED and SUZ12 (ref. 39) . Therefore, we cultured Irf4 -/-Irf8 -/pre-B cells in IL-7, obtained immunoprecipitates by ChIP with anti-STAT5 and analyzed them by immunoblot with anti-EED or anti-SUZ12. We readily detected both components, along with STAT5 and Ezh2 (Fig. 5g) . These data suggested that Ezh2 is recruited to chromatin-bound STAT5 as part of the PRC2 complex.
We next investigated the role of Ezh2 in IL-7-mediated repression of Igk germline transcription. We cloned short hairpin RNA (shRNA) predicted to target Ezh2 into a retroviral vector based on the microRNA miR30 (which also encodes the expression marker GFP), expressed the vectors in Irf4 -/-Irf8 -/cells and isolated GFP + cells by flow cytometry. We found that shRNA 390 and shRNA 1562 inhibited Ezh2 expression by 73% and 37%, respectively (Fig. 5h) . Expression of either shRNA inhibited the IL-7-mediated repression Igk germline transcription, whereas cells expressing shRNA 390 demonstrated an almost complete loss of repression (Fig. 5i) . In conjunction with the findings described above, these data indicated that STAT5-mediated recruitment of Ezh2 to E κi was the main mechanism by which the IL-7R repressed Igk germline transcription.
Tetrameric STAT5-mediated H3K27me3 is not limited to Igk Our data showed that binding of tetrameric STAT5 to E κi recruited Ezh2, which marked Igk with H3K27me3 and repressed germline transcription. To determine if this was a unique feature of Igk transcriptional regulation or a more broadly applicable feature of STAT5 biology, we used anti-STAT5 or anti-H3K27me3 for ChIP of nuclear preparations from Rag2 -/pro-B cells cultured in IL-7, followed by deep sequencing (ChIP-Seq). We obtained 554 peaks for STAT5 and 34,778 peaks for H3K27me3. Examination of the Igk locus showed a strong single STAT5 peak at E κi (Fig. 6a) . There was a corresponding H3K27me3 peak with additional flanking peaks covering the J κ and C κ regions. However, there were no other main STAT5 or H3K27me3 peaks throughout the Igk locus, including regions 5′ of the V κ cluster or at the 3′ C κ enhancer (Fig. 6a and data not shown) . Those findings, which confirmed results obtained with CA-STAT5expressing Irf4 -/-Irf8 -/pre-B cells (Fig. 4c) , indicated that the Igk locus was marked with H3K27me3 only at sites near the recruitment of Ezh2 by STAT5. Consistent with published results 45 , the Igh locus had STAT5-binding sites in the variable heavy-chain (V H ) cluster but no substantial H3K27me3 marks (Fig. 6b) . New prediction of motifs in the STAT5 peaks showed strong association with canonical STAT5-binding sites (P = 5.6 × 10 −32 ; Fig. 6c ). Comparison of the distribution of H3K27me3 and STAT5 peaks identified 53 peaks that overlapped by two or more base pairs ( Fig. 6d) . Of those, 47 were within 25 kb of the known transcriptional start sites of 44 genes (Supplementary Table 2 ). Analysis of those STAT5binding sites demonstrated that all were predicted to have tetrameric STAT5-binding sites (Supplementary Table 3 ). Alignment of each motif ( Supplementary Table 4 ) showed an average STAT5 tetrameric motif containing two consensus STAT5 motifs (5′-TTCN 3 GAA-3′) usually separated by three to eight nucleotides (Fig. 6e) . Notably, all sequences had an incomplete 3′ GAS motif, even though some 5′ sequences were canonical GAS motifs ( Supplementary Table 3 ). a 75 H3K27me3
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Immunoglobulin κ-chain A r t i c l e s These results indicated that the recruitment of STAT5 to tetrameric binding sites was associated with H3K27me3 in vivo.
Concurrent STAT5 and H3K27me3 peaks indicate repression
We next analyzed the relationship between the co-occurrence of STAT5 and H3K27me3 peaks and transcriptional regulation through the use of data available from the Immunological Genome Project (ImmGen) Consortium, which include expression data for 40 of the 44 genes identified above. We normalized expression to that in pro-B cells and then assessed fluctuations as a function of development. The expression of most genes targeted by STAT5 and H3K27me3 together remained unchanged throughout later stages of development ( Fig. 7a) . In contrast, five genes were substantially upregulated after the large pre-B cell stage (Igk, Brwd1, Adar, Wnt16 and Dmrt2), with Igk and Brwd1 being strongly induced. The statistics reported above were limited to genes physically near the overlapping STAT5 and H3K27me3 peaks. Because regulatory interactions can have a long range, we also used the EMBER method (expectation maximization of binding and expression profiles), which integrates ChIP-Seq and gene-expression data to identify gene targets at distances up to 100 kb from transcription binding sites with an unsupervised-machine-learning algorithm. Through the use of EMBER, we integrated our ChIP-Seq data for STAT5 and H3K27me3 with data on expression at B cell developmental stages (from the ImmGen Consortium). We normalized data to expression detected at the pro-B cell stage. These analyses demonstrated that binding of STAT5 at the pro-B cell state, regardless of H3K27me3 marks, was associated with subsequent gene downregulation ( Fig. 7b and Supplementary Fig. 2) . That finding was consistent with an overall activating role for STAT5. For genes associated with STAT5 binding but not H3K27me3 marks ( Fig. 7b and Supplementary Fig. 3) , the pattern of expression was similar to that associated with STAT5 binding regardless of H3K27me3. In contrast, STAT5 binding sites that occurred together with H3K27me3 marks ( Fig. 7b and Supplementary Fig. 4) were associated with stable patterns of expression. These data suggested that the occurrence of STAT5 binding and H3K27me3 together is usually associated with a stable or repressed gene-expression profile.
DISCUSSION
Here we have provided a bimolecular model in which the relative binding of two transcription factors, STAT5 and E2A, to E κi controlled the initiation of Igk germline transcription in pre-B cells. Central to this model was our demonstration that STAT5 bound as a tetramer to E κi and recruited PRC2, which contains Ezh2. Ezh2 then marked E κi , as well as the adjacent J κ cluster and C κ , with H3K27me3. Although other areas of the Igk locus were not marked with H3K27me3, loss of Ezh2 was sufficient for escape from IL-7-mediated Igk repression. This STAT5-mediated repression mechanism ensured that Igk germline transcription was silenced as long as B cell progenitors were productively receiving proliferative signals through the IL-7R. After escape from IL-7R signaling and the loss of activated STAT5, H3K27me3 was lost. The transition to open chromatin was regulated by pre-BCR-mediated induction of free nuclear E2A, which bound E κi and promoted the acquisition of H3K4me1 and H4Ac. In the absence of binding of both STAT5 and E2A, E κi was devoid of the histone modifications assayed. These data suggest that the binding of STAT5 and E2A and the complexes they recruit are sufficient to account for transition of the E κi region from a silenced state to an active state 46 . That conclusion is consistent with published studies demonstrating promiscuous Igk germline transcription in STAT5-deficient early B cell progenitors 31 and observations that both E2A 24 and E κi (ref. 23 ) are required for opening chromatin at Igk.
The epigenetic status of the E κi region was controlled by two transcription factors, which provides an explanation for the tight correlation between Igk germline transcription and accessibility to recombination 11 . In our genome-wide studies, the H3K27me3 mark conferred by STAT5 and Ezh2 binding correlated with transcriptional repression. It is notable that binding of STAT5 was associated with discrete H3K27me3 peaks over E κi as well as J κ and C κ . This suggests that the chromatin in this region is not linear and that the J κ and C κ regions might be positioned over E κi .
In bulk populations of B cell progenitors, the transition between a repressed Igk locus and an active Igk locus seemed complete, with little evidence of much heterogeneity. Those data are consistent with the observation that both Igk alleles are transcriptionally active before Fig. 6 ), presented as change in expression (log 2 ) as a function of B cell development and maturation relative to the pro-B cell stage (ImmGen Consortium). (b) EMBER analysis combining ChIP-Seq results for STAT5 and H3K27me3 with total mouse genome expression microarrays from the ImmGen Consortium, assessing predominant expression patterns of genes within 100 kb of STAT5 binding with or without coincidental H3K27me3 marks for all B cell developmental stages compared with expression at the pro-B cell stage. Coincidence required a minimum overlap of 2 bp. In some instances, more than one gene is within 100 kb of a peak; for example, 69 genes are within 100 kb of the 53 coincident peaks for STAT5 and H3K27me3. Change in mean expression (Activity (key)) is categorized as follows: --, > −3 s. 10 . Presumably, the mechanisms described here, which control Igk transcription and accessibility, do not restrict recombination to one allele (allelic exclusion) 36 . Furthermore, the segregation of the H3K4me1 and H4Ac marks together suggests that there is not an intermediate 'poised' state for E κi in the context of Igk recombination in pre-B cells 22, 46 . Assessment of the relationships between STAT5 and H3K27me3 across the genome of proliferating pro-B cells showed that STAT5 probably functions as a repressor of other genes. Analysis of coincident peaks for H3K27me3 and STAT5 in putative regulatory regions of genes showed that all had tandem GAS motifs, and in all, the 3′ GAS was a partial motif. However, overall the most common nucleotides at each position constituted a canonical GAS motif. These data provide in vivo evidence that for many genes, recruitment of STAT5 to tetrameric binding sites is associated with epigenetic repression. Furthermore, the high correlation between the binding of STAT5 to tetrameric sites and H3K27me3 marks suggested that tetrameric binding to specific DNA sequences may be necessary for epigenetic repression.
The consequences of STAT5-mediated repression may vary depending on the context in which STAT5 binding occurs. Although Igk transcription is induced after entry into the pre-B cell pool, many genes that bound both STAT5 and H3K27me3 in pro-B cells and large pre-B cells remained relatively repressed throughout development and peripheral maturation. This may reflect the fact that in many cases, H3K27me3 is a more stable mark than are other histone post-translational modifications 47 or that STAT5-mediated silencing occurs at some sites together with other, more stable mechanisms of gene repression.
Our data suggest that tetrameric STAT5 recruits Ezh2, which represses a substantial subset of genes regulated by STAT5 during B lymphopoiesis. Furthermore, we predict that this mechanism is relevant to T lymphopoiesis, as the enhancer of the gene encoding the T cell antigen receptor α-chain contains potential STAT5 tetrameric sites abutting several conserved DNA-binding motifs 48 . However, it is unlikely that in general the presence of STAT5 tetramers or of tetrameric binding sites is sufficient to predict gene repression. That is suggested by the observation that STAT5 tetramers can be associated with gene activation and multilineage leukemias 43 . Furthermore, evidence indicates that STAT5 can also repress transcription by recruiting a histone deacetylase and by competing with STAT3 for binding 49 . Such examples indicate that understanding how and when STAT5 represses transcription will require detailed understanding of how STAT5 recruits PRC2 and other repressive complexes.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
